Press Release Lilly’s triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes 19 March 2026
Press Release Lumito and Tethis complete proof-of-concept study demonstrating compatibility between Lumito’s UCNP imaging and Tethis’ SmartBioSurface® slides 19 March 2026
Press Release Cardinal Infrastructure Group Inc. Announces Full Year 2025 Results and Affirms 2026 Guidance 19 March 2026
Press Release DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results 19 March 2026
Press Release Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved in Macao, China 19 March 2026
Press Release X Financial to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 26, 2026 19 March 2026
Press Release No ‘Growth At All Costs’: 74% Of Crypto Providers Choose Verification Accuracy Over Speed – New Sumsub Report 19 March 2026
Press Release Propel Holdings Named “Personal Finance Company of the Year” in 2026 FinTech Breakthrough Awards Program 19 March 2026
